Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,876,873 papers from all fields of science
Search
Sign In
Create Free Account
hepatitis A virus antibodies
Known as:
Anti-HAV
, Antibodies, Hepatitis A
, Hepatitis A Antibodies [Chemical/Ingredient]
Expand
Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Hepatitis A Antibody Measurement
Hepatitis A Antigens
Hepatitis A virus Ab:ACnc:Pt:Ser:Qn:RIA
Immune System Processes
Expand
Broader (1)
Immunologic Factors
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Molecular imprinting based composite cryogel membranes for purification of anti-hepatitis B surface antibody by fast protein liquid chromatography.
Sevgi Asliyuce
,
L. Uzun
,
A. Y. Rad
,
Serhat Unal
,
R. Say
,
A. Denizli
Journal of chromatography. B, Analytical…
2012
Corpus ID: 205779016
2012
2012
Cost‐effectiveness of additional blood screening tests in the Netherlands
B. Borkent‐Raven
,
M. Janssen
,
C. van der Poel
,
G. Bonsel
,
B. van Hout
Transfusion
2012
Corpus ID: 205724557
BACKGROUND: During the past decade, blood screening tests such as triplex nucleic acid amplification testing (NAT) and human T…
Expand
1997
1997
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine.
H. Maiwald
,
W. Jilg
,
H. Bock
,
T. Löscher
,
F. Sonnenburg
Vaccine
1997
Corpus ID: 45197229
1997
1997
Prevalence of Hepatitis A, B, and C markers in school children of a rural area of Crete, Greece
C. Lionis
,
E. Frangoulis
,
Maria Koulentakis
,
E. Biziagos
,
E. Kouroumalis
European Journal of Epidemiology
1997
Corpus ID: 21973565
Objective: To determine the prevalence of hepatitis A, B, and C markers in children who were attending junior and senior high…
Expand
1995
1995
Development and retrospective evaluation of Hepaxpert-I: a routinely-used expert system for interpretive analysis of hepatitis A and B serologic findings
K. Adlassnig
,
W. Horak
Artif. Intell. Medicine
1995
Corpus ID: 9235091
Highly Cited
1994
Highly Cited
1994
Inactivated virosome hepatitis A vaccine
L. Loutan
,
P. Bovier
,
B. Althaus
,
R. Glück
The Lancet
1994
Corpus ID: 206007282
1993
1993
Sensitive assays for hepatitis a antibodies
W. Miller
,
W. Clark
,
W. Hurni
,
B. Kuter
,
T. Schofield
,
D. Nalin
Journal of Medical Virology
1993
Corpus ID: 31931092
Two commercial assay kits for detecting antibody to hepatitis A virus (anti‐HAV) have been modified in order to increase their…
Expand
Highly Cited
1993
Highly Cited
1993
Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.
Manfred S. Green
,
Dani Cohen
,
+10 authors
Michael Wiener
Journal of Infectious Diseases
1993
Corpus ID: 35100630
Inactivated hepatitis A virus (HAV) vaccine is given in a three-dose schedule. When rapid protection is needed, injection of…
Expand
Highly Cited
1980
Highly Cited
1980
Comparison of solid phase test systems for demonstrating antibodies against hepatitis a virus (anti‐hav) of the igm‐class
Michael Roggendorf
,
G. Frösner
,
F. Deinhardt
,
R. Scheid
Journal of Medical Virology
1980
Corpus ID: 25902309
Three methods were compared for determining anti‐HAV of the IgM class. In the first method flat‐bottomed microtiter plates coated…
Expand
Highly Cited
1977
Highly Cited
1977
Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay
D. Bradley
,
J. Maynard
,
+4 authors
E. Cook
Journal of Clinical Microbiology
1977
Corpus ID: 26931312
A modified micro solid-phase radioimmunoassay (RIA) for antibody to hepatitis A virus (anti-HAV) was developed. This double…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE